Abstract
There is intense crosstalk between mitochondria and the nucleus that is mediated by proteins and long noncoding RNAs (lncRNAs). Using a modified RNA fluorescent in situ hybridization (RNA-FISH) assay coupled with MitoTracker staining, we tracked the mitochondrial localization of lncRNAs, including lncND6 and lncCytB. The nuclear genome-transcribed lncRNA MALAT1 was enriched in the mitochondria of hepatocellular carcinoma cells. Knockdown of MALAT1 significantly impaired mitochondrial function and alter tumor phenotype in HepG2 cells. The localization of the mitochondria-encoded lncRNA lncCytB was also abnormal in HepG2 cells. In normal hepatic HL7702 cells, lncCytB was located in mitochondria, but in HepG2 cells, it was enriched considerably in the nucleus. These data suggest that aberrant shuttling of lncRNAs, whether nuclear genome-encoded or mitochondrial genome-transcribed, may play a critical role in abnormal mitochondrial metabolism in cancer cells. This data lays the foundation for further clarifying the roles of mitochondria-associated lncRNAs in cancers.
Keywords: Mitochondria, lncRNAs, hepatocarcinoma, mitochondria-nuclear crosstalk, mitochondrial metabolism
Introduction
Mitochondria are essential cellular organelles that regulate energy generation, calcium signaling, and intrinsic apoptotic pathways in cancer [1,2]. There exists a mitochondria-nuclear crosstalk that serves as a pathway of communication to influence many cellular and organismal activities. This bidirectional crosstalk can regulate several oncogenic pathways involved in tumorigenesis [3]. The mechanism whereby proteins are imported into mitochondria has been a topic of intense investigation [4,5] ever since the first report of tRNA transport from cytoplasm to mitochondria a half-century ago [6].
The use of next-generation RNA sequencing has led to the surprising discovery that numerous nuclear genome-encoded long noncoding RNAs (lncRNAs), including RMRP and RPPH1, may localize to mitochondria [6-9]. Recent studies suggest that mitochondrial lncRNAs, whether encoded by the mitochondrial genome or encoded by the nuclear genome and then transported into the mitochondria, may play an essential role in mitochondrial metabolism [9-11]. In order to explore the physiologic roles of these lncRNAs, it would be ideal to have a method to actually visualize these molecules within an organelle in an individual cell. This would require a new approach, like RNA-fluorescent in situ hybridization (FISH), in conjunction with a method to simultaneously identify mitochondria.
In this paper, we used a modified RNA-FISH approach to track lncRNAs that are enriched within the mitochondria. Using this approach, we demonstrate the localization of both the mitochondria-encoded RNAs and nuclear genome-encoded lncRNAs in isolated mitochondria and in whole cells. We show that there was abnormal mitochondria-nuclear crosstalk of lncCytB in hepatoma cells, suggesting a new function of this lncRNA as a mitochondria-nuclear communicator in cancer cell homeostasis. We further show that the nuclear genome-encoded lncRNA MALAT1 was enriched in mitochondria, where it functions as a critical epigenetic player in the regulation of mitochondrial function. Together, this study greatly expands our knowledge of how nucleus-encoded lncRNAs can modulate the function of mitochondria.
Materials and methods
Hepatic cell lines
Hepatocellular carcinoma cell line HepG2 was purchased from ATCC and cultured in high glucose DMEM (Invitrogen, CA) supplemented with 10% FBS, 100 U/ml Penicillin-Streptomycin. Normal hepatic cell line HL7702 was purchased from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China) and was cultured in high glucose DMEM supplemented with 20% FBS (Invitrogen, CA), 1× Non-Essential Amino Acid (NEAA, Invitrogen, CA) 100 U/ml Penicillin-Streptomycin (Invitrogen, CA). Cells were incubated at 37°C in 5% CO2 air atmosphere.
Cell level RNA-FISH
We used a modified RNA-FISH assay to track lncRNAs in mitochondria (Figure 1A). In this assay, we used asymmetric PCR to selectively amplify the probe strand by adding digoxigenin-labeled dNTP. Asymmetric PCR was used to over-amplify the antisense strand of the cDNA template using an unbalanced ratio of primers. In asymmetric PCR, excessive amounts of the complementary primer were added to the reaction mixture. The method also required additional PCR cycles due to the slower amplification that occurred later in the reaction cycle, when the limiting primer has been depleted [12]. By replacing dTTP with digoxigenin (DIG)-dUTP, asymmetric PCR synthesizes single-stranded, DIG-labeled DNA probes. In order to assess mitochondrial localization of lncRNAs, we counterstained the mitochondria by MitoTracker™ (MitoTracker™ Red CMXRos Cat: M7512 Invitrogen™) and lncRNAs using spectrally distinct fluorophores to verify their co-localization. The next step was to use FITC conjunct antibody to detect the lncRNA interacted probe. This increased the output signal by using secondary reporters that bind to the hybridization probes.
Figure 1.
Detection of RNAs in mitochondria by the combined RNA fluorescent in situ hybridization (RNA-FISH) and MitoTracker staining. A. The principle of asymmetric PCR-derived single-stranded DNA probes in RNA-FISH for lncRNA localization in mitochondria. B. Mitochondrial localization of lncRNA lncND6. Mitochondria-encoded MT-CO2 RNA, as a mitochondrion positive control, is localized in mitochondria. U6 snRNA, encoded by the nuclear genome, is used as a negative control and is localized in the nucleus. MitoTracker was used to stain mitochondria. As expected, lncND6 is primarily located in the mitochondria of HepG2 cells.
Mitochondrial level RNA-FISH
Mitochondria are not the only organelles in the cytoplasm. To rule out the possibility that lncRNAs are located within the cytoplasm but outside of the mitochondria, we performed the RNA-FISH staining method in isolated mitochondria. Mitochondria isolation was performed following the protocol provided by the Mitochondria isolation kit (Qproteome Mitochondria Isolation Kit. Cat: 37612). Before mitochondria isolation, live mitochondria were stained by MitoTracker™. After mitochondria isolation, RNA-FISH was applied to the mitochondria slides. The detailed reagents and step-by-step procedure are summarized in Supplementary Materials and the primers for asymmetric PCR are listed in Table S1.
MALAT1 knockdown
To study the role of MALAT1 in HepG2 cells, we used shRNAs to knockdown MALAT1. Briefly, short hairpin RNAs (shRNAs) against the 3’ region of MALAT1 mRNA were inserted into a lentiviral vector. The shMALAT1 1# sequence was 5’-CACAGGGAAAGCGAGTGGTTGGTAA-3’ and shMALAT1 2# sequence was 5’-GATCCATAATCGGTTTCAAGGTA-3’. After confirmation by DNA sequencing, the lentiviruses were packaged in 293T cells using polyethylenimine (PEI, 5 µg/µl). The virus-containing supernatants were collected and concentrated with centrifugal Filter Units (Amicon Ultra-15, Millipore, MA). HepG2 cells in 6-well plates were infected with lentiviruses using polybrene (8 μg/ml). Three days after infection, HepG2 cells were selected by puromycin, and mixed stable cells were collected for each shRNA group and used for gene analysis by RT-PCR.
ATP determination assay
The ATP levels in control HepG2 and shMALAT1 cells were measured by an Enhanced ATP Assay Kit (S0027, Beyotime Biotechnology, Shanghai, China), according to the manufacturer’s instructions [13]. The concentration of ATP was calculated according to an ATP standard curve and expressed as nmol/OD730. ATP levels were reported as nmol/mg of protein.
Transwell assay
Cell migration capability was measured using a 6-well Corning BioCoat Matrigel Invasion Chamber with a membrane. About 5×104 cells in 2.0 ml high glucose DMEM media without FBS were placed into the upper chambers. The lower chambers were filled with 2.5 ml complete medium with 10% FBS as a chemo-attractant stimulus. After incubation for 24 hours at 37°C, non-invading cells were removed from the top of the chamber with a cotton swab. Migrated cells on the bottom surface of the filter were fixed, stained with 0.5% crystal violet, and counted in five random fields under a microscope, and the average number of five fields was calculated.
Epithelial-mesenchymal transition (EMT) model establishment
TGF-β has been shown to be a key driver of hepatocellular oncogenesis, promoting EMT [14]. Therefore, we used TGF-β1 as an EMT inducer. EMT was induced by TGF-β1 (PeproTech, Rocky Hill, NJ) following the reported protocol [15,16]. Briefly, cells were seeded into 15cm plates. Following 24 h incubation, EMT-inducing medium (containing 10ng/ml TGF-β1) was used to replace the common medium and the cells were incubated for an additional 72 h.
Cellular fractionation assay
As previously described [17], cellular fractions were separated by NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific) with RNase inhibitor (Thermo Scientific). After separation, RNAs were extracted from nuclear and cytoplasmic fractions using Trizol (Life Technologies, Carlsbad, CA), and were converted into cDNA with the SuperScript™ III RT (Invitrogen). The real-time Q-PCR was performed using 2X RealStar Power SYBR Mixture (GenStar A311). The relative expression was calculated on the basis of CT values against an internal standard curve for each specific set of primers. The data were normalized over the value of β-actin control.
Results
Localization of mitochondrial DNA-encoded lncRNAs by RNA-FISH
To study the role of lncRNAs in mitochondria-nuclear crosstalk, we used a modified RNA-FISH method to detect the localization of mitochondria-associated long non-coding RNA and protein-coding RNA in mitochondria (Figure 1A). The mitochondria-encoded MT-CO2 mRNA was chosen as a positive control. As expected, MT-CO2 mRNA was located in the mitochondria, as seen by the green fluorescence of the RNA that merged with the red-stained mitochondria using MitoTracker (Figure 1B, orange). U6, a well-known nuclear lncRNA, was chosen as a negative control [18]. As expected, the U6 probe overlapped with DAPI staining in the nucleus (Figure 1B, cyan). We also observed that lncND6, a mitochondria-encoded lncRNA [19], was localized in mitochondria.
Nuclear genome-encoded lncRNAs (NG-lncRNAs) in mitochondria
To study the shuttling of lncRNAs between the mitochondria and the nucleus, we also performed the RNA-FISH assay for nuclear genome-encoded lncRNAs, including RMRP (RNA component of mitochondrial RNA processing endoribonuclease) and RPPH1 (ribonuclease P RNA component H1). The mitochondrial localization of these two lncRNAs was previously discovered by mitochondria RNA-sequencing [6,7], but had not been confirmed by RNA-FISH. Mitochondria are not the only cytoplasmic organelles, so to rule out the possibility that lncRNAs are located in the cytoplasm but outside of the mitochondria, we applied this staining method to isolated mitochondria.
Figure 2A showed that RMRP and RPPH1 were located in the isolated mitochondria. Compared with whole cell FISH, this method avoids interference from other cytoplasmic organelles. The abundance of the lncRNAs varied from one mitochondrion to another. When there was a high abundance of lncRNAs in the mitochondria, the FISH color was yellow. When lncRNAs are not abundant, the color appeared to be more orange. Both lncRNAs were abundantly localized in mitochondria.
Figure 2.

Detection of the nuclear-encoded lncRNAs in mitochondria. A. Detection of the nuclear-encoded lncRNAs in mitochondria on isolated mitochondria smear slides. MitoTracker was used to stain mitochondria (red). RMRP and RPPH1 are shown in isolated mitochondria (arrows). B. Staining of the nuclear-encoded lncRNA RMRP and RPPH1 in the mitochondria of HepG2 cells. DAPI was used to stain nuclear DNA. MitoTracker was used to stain mitochondria. Arrows: the merged color of lncRNAs (green) and MitoTracker (red).
We also compared the location of these two lncRNAs in whole cells. The nucleus was stained with the DAPI dye. As shown in Figure 2B, the lncRNA probe (green) overlaid with MitoTracker™ (red) and the merged color changed from red to orange, depending on the abundance of the lncRNAs. Thus, our modified mitochondrial RNA-FISH method can be used to track the exchange of lncRNAs between the nucleus and mitochondria.
Aberrant shuttling of lncRNA lncCytB in hepatoma cells
We also compared the mitochondria-nuclear localization of mitochondrial DNA-encoded lncRNAs between hepatoma and normal hepatic cells. LncCytB is a mitochondria-encoded lncRNA. In normal liver HL7702 cells, RNA-FISH staining indicated that lncCytB was localized primarily in the mitochondria. In hepatoma HepG2 cells, however, we found that lncCytB was not only present in the mitochondria but was also detected in the nucleus (Figure 3A). Notably, the abundance of lncCytB was much higher in the nucleus.
Figure 3.
Differential positioning of the mitochondrial-encoded lncRNA lncCytB in normal liver cells (HL7702), hepatoma cells (HepG2) and HepG2-EMT. A. RNA-FISH staining. In HL7702 cells, lncCytB is primarily located in mitochondria. In HepG2 cells, however, lncCytB is aberrantly transported to the nucleus. B. Q-PCR quantitation. The cellular fractionation assay showed lncCytB is largely enriched in the nucleus compared to the cytoplasm. *P = 0.0277, unpaired t-test. C. RNA-FISH in HepG2-wild type and HepG2-EMT cells. After induction of EMT with TGF-β1, cells were stained by RNA-FISH. The mitochondrial genome-encoded lncRNA lncCytB is dominated in the nucleus.
We also used the cellular fractionation assay to confirm the location of lncCytB in the nucleus in HepG2 cells. Cytoplasmic and nuclear RNAs were isolated and were reverse transcribed into cDNAs. Using Q-PCR, we also confirmed that the abundance of lncCytB was significantly higher in the nucleus than in the cytosol (Figure 3B).
Accumulating evidence supports the role of epithelial-mesenchymal transition (EMT) in tumor cell progression, invasion, and metastasis. Such transformation promotes cancer migration and invasion. We thus examined if EMT would alter the localization of lncRNAs. We induced EMT in HepG2 cells using TGF-β1 and performed RNA-FISH to check the localization of lncCytB. We fund that EMT did not significantly alter the localization of lncCytB in the nucleus (Figure 3C).
Collectively, these data suggest that lncCytB may function as a messenger communicating between the nucleus and mitochondria. Further studies are needed to address whether the aberrant location of the lncCytB may relate to characteristic malignant characteristics of the cancer cell, such as the Warburg effect [20].
The role of nuclear genome-encoded MALAT1 in mitochondria
Currently, we know very little about the role of the mitochondria-localized lncRNAs, particularly those that are encoded in the nuclear genome. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) was originally thought to be a nucleus-enriched lncRNA [21]. Recently, we found that the nuclear genome-encoded MALAT1 was also enriched in mitochondria in hepatoma HepG2 cells. Thus, we isolated mitochondria and performed RNA-FISH on smear slides. We found that the probe enriched area (green) coincided with that of the MitoTracker staining (Figure 4A). Thus, MALAT1, although encoded by the nuclear genome, was also enriched in the mitochondria collected from HepG2 cells.
Figure 4.

The nuclear lncRNA MALAT1 is enriched in HepG2 mitochondria. A. RNA-FISH of MALAT1 in isolated HepG2 mitochondria. MALAT1 is localized in the isolated mitochondria that are stained in red with the MitoTracker dye. B. Differential enrichment of MALAT1 lncRNA in the mitochondria of normal and malignant cells. HepG2: hepatocellular carcinoma cell; HL7702: normal hepatic cell; MT-ND5 and MT-ND6: mitochondrial ND5 and ND6 mRNAs as the positive control. Note that MALAT1 is barely detectable in normal H7702 mitochondria. C. MALAT1 knockdown impaired the mitochondrial ATP production ability. ** P < 0.01, ordinary one-way ANOVA. D. Knockdown of MALAT1 significantly inhibited invasion of HepG2 cell.
We then used PCR to compare the abundance of MALAT1 in the mitochondria from normal hepatic HL7702 cells and from hepatoma HepG2 cells (Figure 4B). As the positive controls, the mitochondrial genome-encoded ND5 and ND6 mRNAs were detected in both cells (lanes 3-4). However, we found that MALAT1 was abundantly enriched in the HepG2 mitochondria, but was barely detectable in the HL7702 mitochondria (lane 2). Further studies are needed to compare mitochondrial MALAT1 in clinical samples, including hepatoma, the adjacent tissues, and normal hepatic tissues.
To understand the role of MALAT1 in mitochondrial biogenesis and energetics, we knocked down MALAT1 using shRNA lentiviruses in hepatoma HepG2 cells. We found that the MALAT1-deficient HepG2 cells produced less ATP than the vector and random shRNA control cells (Figure 4C). Therefore, the mitochondrial enrichment of MALAT1 may be a critical process to regulate energy metabolism in HepG2 cells.
We examined if knockdown of MALAT1 will affect the tumor phenotype in HepG2 cells. Using the Transwell assay, we showed that cell invasion was lower in shMALAT1-treated cells than that in vector control (Vector) and shRNA random control (shCT) cells (Figure 4D). These results indicate that down-regulation of MALAT1 impaired the cell invasion in vitro.
Discussion
An intense crosstalk between mitochondria and the nucleus, mediated by proteins as well as ncRNAs, is required for cellular homeostasis [22]. Using a modified RNA-FISH, we tracked the mitochondrial localization of the lncRNAs lncND6 and lncCytB in hepatocellular carcinoma cells (HepG2) and normal hepatic cells (HL7702). Interestingly, we demonstrated that the oncogenic lncRNA MALAT1 that is encoded by the nuclear genome, is also enriched in the HepG2 mitochondria. Using shRNA knockdown, we show that MALAT1 is critical for maintaining normal mitochondrial function. The mitochondria-encoded lncRNA lncCytB, on the other hand, is aberrantly transported to the nucleus in hepatoma HepG2 cells as compared with normal hepatic HL7702 cells. Collectively, our data reveal a previously unreported shuttling of lncRNAs during the mitochondria-nucleus crosstalk. The aberrant shuttling of lncRNAs in this crosstalk may be associated with abnormal energy metabolism in hepatoma cells (Figure 5).
Figure 5.

The model of the mitochondria-nuclear shuttling of lncRNAs. RMRP, RPPH1, and MALAT1 are all the nuclear genome-encoded lncRNAs. They function as anterograde signals to communicate between the mitochondria and the nucleus. On the other hand, lncCytB is a mitochondrial genome-encoded retrograde signal. It shuttles from the mitochondria to the nucleus in hepatoma cells. The aberrant shuttling of lncRNAs in this mitochondria-nucleus crosstalk may be associated with abnormal energy metabolism in malignant cells.
RMRP is the first reported lncRNA that is encoded by a single-copy gene in the nucleus and then imported into mitochondria [23]. Using in situ hybridization analysis, Li and colleagues showed that RMRP is present in mitochondria, though with a relatively low abundance as compared with the nucleus [24]. In this study, using HepG2 cells as a model we also showed the presence of considerable amounts of RMRP in mitochondria, confirming that nuclear lncRNAs can shuttle from the nucleus to mitochondria.
MALAT1, a nuclear genome-encoded lncRNA, has previously been associated with tumorigenicity in a variety of malignancies [25,26]. It regulates the expression of metastasis-associated genes and cell motility at the transcriptional and/or post-transcriptional levels, regulating the activity of motility-related genes [27,28]. Since MALAT1 regulates mitochondrial apoptosis and mitophagy, it has been suggested that MALAT1 may function as a regulator of mitochondrial metabolism [22,29,30]. Our study provides evidence that MALAT1 may act as a nucleus-to-mitochondria messenger, as MALAT1 is transported from the nucleus to the mitochondria in hepatoma HepG2 cells. Knockdown of MALAT1 affects mitochondrial function. These data suggest that after being transported into mitochondria, MALAT1 may directly alter mitochondrial metabolism in hepatoma cells. In normal hepatic HL7702 cells, however, the level of MALAT1 in mitochondria is very low. It will be interesting to explore if mitochondrial MALAT1 is associated with disease progression and tumor survival.
Our results support the concept that retrograde and anterograde signaling occurs as lncRNAs shuttle between the nucleus and mitochondria crosstalk [8,9]. In this crosstalk (Figure 5), lncRNAs function as epigenetic messengers, altering mitochondrial metabolism during oncogenesis. In this study, we show that the mitochondrial genome-encoded lncCytB is a typical example of a signaling lncRNA. In normal liver HL7702 cells, lncCytB is localized primarily in the mitochondria. In hepatoma HepG2 cells, however, this lncRNA is transported into the nucleus. Future work is needed to determine the mechanism underlying this translocation or shuttling.
In summary, this study greatly expands our knowledge that the nucleus-encoded lncRNAs, like MALAT1, may act as epigenetic regulators to alter the mitochondrial function. The mitochondria-derived lncRNAs, on the other hand, may also shuttle into the nucleus, where they may regulate target genes related to tumor phenotypes. This study thus suggests novel biological functions for lncRNAs and lays the foundation for further clarifying the roles of mitochondrial lncRNAs.
Acknowledgements
This work was supported by the National Key R&D Program of China (2018YFA0106902), the Key Project of Chinese Ministry of Education grant (311015), the National Basic Research Program of China (973 Program) (2015CB943303), Nation Key Research and Development Program of China grant (2016YFC13038000), National Natural Science Foundation of China (31430021, 81874052, 81672275, 31871297, 81670143), Research on Chronic Noncommunicable Diseases Prevention and Control of National Ministry of Science and Technology (2016YFC1303804), National Health Development Planning Commission Major Disease Prevention and Control of Science and Technology Plan of Action, Cancer Prevention and Control (ZX-07-C2016004), Natural Science Foundation of Jilin Province (20150101176JC, 20180101117JC, 20130413010GH), and California Institute of Regenerative Medicine (CIRM) grant (RT2-01942); and the Department of Veterans Affairs (BX002905).
Disclosure of conflict of interest
None.
Supporting Information
References
- 1.Singh KK, Costello LC. Mitochondria and cancer. Springer; 2009. [Google Scholar]
- 2.Corbet C, Feron O. Cancer cell metabolism and mitochondria: nutrient plasticity for TCA cycle fueling. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2017;1868:7–15. doi: 10.1016/j.bbcan.2017.01.002. [DOI] [PubMed] [Google Scholar]
- 3.Mello T, Simeone I, Galli A. Mito-Nuclear Communication in Hepatocellular Carcinoma Metabolic Rewiring. Cells. 2019;8:E417. doi: 10.3390/cells8050417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Chacinska A, Koehler CM, Milenkovic D, Lithgow T, Pfanner N. Importing mitochondrial proteins: machineries and mechanisms. Cell. 2009;138:628–644. doi: 10.1016/j.cell.2009.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Schmidt O, Pfanner N, Meisinger C. Mitochondrial protein import: from proteomics to functional mechanisms. Nat Rev Mol Cell Biol. 2010;11:655–667. doi: 10.1038/nrm2959. [DOI] [PubMed] [Google Scholar]
- 6.Kim KM, Noh JH, Abdelmohsen K, Gorospe M. Mitochondrial noncoding RNA transport. BMB Rep. 2017;50:164–174. doi: 10.5483/BMBRep.2017.50.4.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Noh JH, Kim KM, Abdelmohsen K, Yoon JH, Panda AC, Munk R, Kim J, Curtis J, Moad CA, Wohler CM, Indig FE, de Paula W, Dudekula DB, De S, Piao Y, Yang X, Martindale JL, de Cabo R, Gorospe M. HuR and GRSF1 modulate the nuclear export and mitochondrial localization of the lncRNA RMRP. Genes Dev. 2016;30:1224–1239. doi: 10.1101/gad.276022.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Zhao Y, Sun L, Wang RR, Hu JF, Cui J. The effects of Mitochondria-associated long noncoding RNAs in cancer mitochondria: new players in an old arena. Critical Reviews in Oncology/Hematology. 2018 doi: 10.1016/j.critrevonc.2018.08.005. [DOI] [PubMed] [Google Scholar]
- 9.Dong Y, Yoshitomi T, Hu JF, Cui J. Long noncoding RNAs coordinate functions between mitochondria and the nucleus. Epigenetics Chromatin. 2017;10:41. doi: 10.1186/s13072-017-0149-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Vendramin R, Marine JC, Leucci E. Non-coding RNAs: the dark side of nuclear-mitochondrial communication. EMBO J. 2017;36:1123–1133. doi: 10.15252/embj.201695546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wang Y, Hu SB, Wang MR, Yao RW, Wu D, Yang L, Chen LL. Genome-wide screening of NEAT1 regulators reveals cross-regulation between paraspeckles and mitochondria. Nat Cell Biol. 2018;20:1145–1158. doi: 10.1038/s41556-018-0204-2. [DOI] [PubMed] [Google Scholar]
- 12.Heiat M, Ranjbar R, Latifi AM, Rasaee MJ, Farnoosh G. Essential strategies to optimize asymmetric PCR conditions as a reliable method to generate large amount of ssDNA aptamers. Biotechnol Appl Biochem. 2017;64:541–548. doi: 10.1002/bab.1507. [DOI] [PubMed] [Google Scholar]
- 13.Zhou J, Zhang F, Meng H, Zhang Y, Li Y. Introducing extra NADPH consumption ability significantly increases the photosynthetic efficiency and biomass production of cyanobacteria. Metab Eng. 2016;38:217–227. doi: 10.1016/j.ymben.2016.08.002. [DOI] [PubMed] [Google Scholar]
- 14.Giannelli G, Villa E, Lahn M. Transforming growth factor-beta as a therapeutic target in hepatocellular carcinoma. Cancer Res. 2014;74:1890–1894. doi: 10.1158/0008-5472.CAN-14-0243. [DOI] [PubMed] [Google Scholar]
- 15.Moreno-Bueno G, Peinado H, Molina P, Olmeda D, Cubillo E, Santos V, Palacios J, Portillo F, Cano A. The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat Protoc. 2009;4:1591–1613. doi: 10.1038/nprot.2009.152. [DOI] [PubMed] [Google Scholar]
- 16.Xu Z, Shen MX, Ma DZ, Wang LY, Zha XL. TGF-beta1-promoted epithelial-to-mesenchymal transformation and cell adhesion contribute to TGF-beta1-enhanced cell migration in SMMC-7721 cells. Cell Res. 2003;13:343–350. doi: 10.1038/sj.cr.7290179. [DOI] [PubMed] [Google Scholar]
- 17.Li L, Li W, Chen N, Zhao H, Xu G, Zhao Y, Pan X, Zhang X, Zhou L, Yu D. FLI1 exonic circular RNAs as a novel oncogenic driver to promote tumor metastasis in small cell lung cancer. Clinical Cancer Research. 2019;25:1302–1317. doi: 10.1158/1078-0432.CCR-18-1447. [DOI] [PubMed] [Google Scholar]
- 18.Spiller MP, Boon KL, Reijns MA, Beggs JD. The Lsm2-8 complex determines nuclear localization of the spliceosomal U6 snRNA. Nucleic Acids Res. 2007;35:923–929. doi: 10.1093/nar/gkl1130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rackham O, Shearwood AM, Mercer TR, Davies SM, Mattick JS, Filipovska A. Long noncoding RNAs are generated from the mitochondrial genome and regulated by nuclear-encoded proteins. RNA. 2011;17:2085–2093. doi: 10.1261/rna.029405.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Liberti MV, Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci. 2016;41:211–218. doi: 10.1016/j.tibs.2015.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Gutschner T, Hammerle M, Diederichs S. MALAT1 -- a paradigm for long noncoding RNA function in cancer. J Mol Med (Berl) 2013;91:791–801. doi: 10.1007/s00109-013-1028-y. [DOI] [PubMed] [Google Scholar]
- 22.De Paepe B, Lefever S, Mestdagh P. How long noncoding RNAs enforce their will on mitochondrial activity: regulation of mitochondrial respiration, reactive oxygen species production, apoptosis, and metabolic reprogramming in cancer. Curr Genet. 2018;64:163–172. doi: 10.1007/s00294-017-0744-1. [DOI] [PubMed] [Google Scholar]
- 23.Topper JN, Bennett JL, Clayton DA. A role for RNAase MRP in mitochondrial RNA processing. Cell. 1992;70:16–20. doi: 10.1016/0092-8674(92)90529-l. [DOI] [PubMed] [Google Scholar]
- 24.Li K, Smagula CS, Parsons WJ, Richardson JA, Gonzalez M, Hagler HK, Williams RS. Subcellular partitioning of MRP RNA assessed by ultrastructural and biochemical analysis. J Cell Biol. 1994;124:871–882. doi: 10.1083/jcb.124.6.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Yu B, Shan G. Functions of long noncoding RNAs in the nucleus. Nucleus. 2016;7:155–166. doi: 10.1080/19491034.2016.1179408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wu Y, Huang C, Meng X, Li J. Long noncoding RNA MALAT1: insights into its biogenesis and implications in human disease. Curr Pharm Des. 2015;21:5017–5028. doi: 10.2174/1381612821666150724115625. [DOI] [PubMed] [Google Scholar]
- 27.Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, Ijiri K, Akimitsu N. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 2010;584:4575–4580. doi: 10.1016/j.febslet.2010.10.008. [DOI] [PubMed] [Google Scholar]
- 28.Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, Zornig M, MacLeod AR, Spector DL, Diederichs S. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73:1180–1189. doi: 10.1158/0008-5472.CAN-12-2850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Liang J, Liang L, Ouyang K, Li Z, Yi X. MALAT1 induces tongue cancer cells’ EMT and inhibits apoptosis through Wnt/beta-catenin signaling pathway. J Oral Pathol Med. 2017;46:98–105. doi: 10.1111/jop.12466. [DOI] [PubMed] [Google Scholar]
- 30.Li LJ, Chai Y, Guo XJ, Chu SL, Zhang LS. The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma. Biomed Pharmacother. 2017;89:939–948. doi: 10.1016/j.biopha.2017.02.011. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


